glp-1 cardiovascular outcomes trial august 2025 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes Cardiovascular outcomes of semaglutide and
Description
Metformin and gut microbiota: their interactions and their impact on diabetes
and Eric D
Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation
SMD 0.114)
: Akkermansia muciniphila, Clostridium butyricum Bifidobacterium infantis
I 2 = 0
